HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N- ethoxymethyl- 3- amino- 1,2,4- benzotriazine- 1,4- dioxide

an antineoplastic agent; structure in first source

Also Known As:

XQ2 N-oxide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Triazines: 306
    - N-ethoxymethyl-3-amino-1,2,4-benzotriazine-1,4-dioxide: 1
- Heterocyclic Oxides
  - Cyclic N-Oxides: 3
    - N-ethoxymethyl-3-amino-1,2,4-benzotriazine-1,4-dioxide: 1

Experts

1.	He, Qiaojun: 1 article (01/2010)
2.	Hu, Yongzhou: 1 article (01/2010)
3.	Lou, Jianshu: 1 article (01/2010)
4.	Luo, Peihua: 1 article (01/2010)
5.	Wang, Duo-duo: 1 article (01/2010)
6.	Weng, Qinjie: 1 article (01/2010)
7.	Xia, Qing: 1 article (01/2010)
8.	Yang, Bo: 1 article (01/2010)
9.	Zhou, XingLu: 1 article (01/2010)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2010 - "Here we investigated a synthetic TPZ derivative, N-ethoxymethyl-3-amino-1,2,4-benzotriazine-1,4-dioxide (XQ2), a novel compound that induced anti-cancer effects both in normoxia and in hypoxia, cell proliferation assay found that XQ2 exhibited a potent inhibitory effect on the tested cancer cell lines both in normoxia and in hypoxia. "
2.	Hypoxia (Hypoxemia) 01/01/2010 - "Here we investigated a synthetic TPZ derivative, N-ethoxymethyl-3-amino-1,2,4-benzotriazine-1,4-dioxide (XQ2), a novel compound that induced anti-cancer effects both in normoxia and in hypoxia, cell proliferation assay found that XQ2 exhibited a potent inhibitory effect on the tested cancer cell lines both in normoxia and in hypoxia. "